IntelGenx receives final approval to graduate to Toronto Stock Exchange

IntelGenx receives final approval to graduate to Toronto Stock Exchange
Share this article

SAINT LAURENT – IntelGenx Technologies Corp. (TSXV: IGX) (OTCQB: IGXT) announced that it has received final approval to graduate to the Toronto Stock Exchange from the TSX Venture Exchange. The Company’s shares of common stock, 8% convertible debentures with a maturity date of June 30, 2022, and share purchase warrants expiring on February 11, 2023 are expected to commence trading on the TSX at market open on Thursday, October 7, 2021 under the existing stock symbols “IGX”, “IGX.DB” and “IGX.WT”, respectively.

“The TSX is Canada’s most prestigious and senior exchange,” commented Dr. Horst G. Zerbe, CEO of IntelGenx. “This graduation marks an important milestone for IntelGenx, and we believe that it will help us develop a stronger profile in the investment community.”

The Common Shares, Convertible Debentures and Warrants will be delisted from the TSXV concurrently with the commencement of trading on the TSX. Holders of Common Shares, Convertible Debentures and Warrants are not required to take any action in connection with the graduation.

IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films.

IntelGenx’s superior film technologies, including VersaFilm®, DisinteQ™, VetaFilm™ and transdermal VevaDerm™, allow for next-generation pharmaceutical products that address unmet medical needs. IntelGenx’s innovative product pipeline offers significant benefits to patients and physicians for many therapeutic conditions.

IntelGenx’s highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx’s state-of-the-art manufacturing facility offers full service by providing lab-scale to pilot- and commercial-scale production.

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.